Great changes are occurring in the financing of health care in America, which are in turn influencing the clinical care of individuals with sickle cell disease (SCD). One great changes has been the use of long acting antibiotics to lower the rate of admission for febrile illness in SCD. The Children's Hospital of Philadelphia has recently instituted a extended stay acute care unit to further attempt to reduce the number of hospitalizations for febrile illness in children with SCD. This project will construct a detailed cost identification model of four alternative approaches to the management of febrile illness in children with SCD. The study will consist of five tasks: (1) To conduct a cost identification study; 92) To estimate patient/family direct and indirect costs associated with a febrile episode in the hospital; (3) To pilot a revised algorithm for the management of febrile illness after analyzing two years of cost data; (4) To perform a second cost identification study using data generated under a revised febrile illness algorithm; and (5) To propose final recommendations regarding the management of febrile illness based on the economic data collected from these studies. This study will analyze results from three different perspectives: the patient/family, the hospital, and society. The project will examine equally efficacious algorithms concerning the prevention of sepsis in SCD. However, since costs to the family may influence compliance with these disease management algorithms, the results of the proposed study may have important medical as well as economic implications. There have been no detailed cost analyses of the alternative approaches to febrile illness in SCD, and especially lacking is any data on the economic impact of these alternative approaches on the family and individual patient. In an era of cost containment, this study should provide fundamental information needed to rationally manage limited resources for this chronically ill population.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL038632-15
Application #
6600036
Study Section
Project Start
2002-04-01
Project End
2003-03-31
Budget Start
Budget End
Support Year
15
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ballas, Samir K; Connes, Philippe; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (2018) Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and ?-thalassemia. Eur J Haematol 101:798-803
Kwiatkowski, Janet L; Zimmerman, Robert A; Pollock, Avrum N et al. (2009) Silent infarcts in young children with sickle cell disease. Br J Haematol 146:300-5
Adachi, Kazuhiko; Ding, Min; Asakura, Toshio et al. (2009) Relationship between beta4 hydrogen bond and beta6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S. Arch Biochem Biophys 481:137-44
Kiryu, Shigeru; Sundaram, Tessa; Kubo, Shigeto et al. (2008) MRI assessment of lung parenchymal motion in normal mice and transgenic mice with sickle cell disease. J Magn Reson Imaging 27:49-56
Niebanck, Alison E; Pollock, Avrum N; Smith-Whitley, Kim et al. (2007) Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr 151:67-72, 72.e1
Uematsu, Hidemasa; Takahashi, Masaya; Hatabu, Hiroto et al. (2007) Changes in T1 and T2 observed in brain magnetic resonance imaging with delivery of high concentrations of oxygen. J Comput Assist Tomogr 31:662-5
Obata, Kazuo; Mattiello, Julian; Asakura, Kenji et al. (2006) Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes. Am J Hematol 81:26-35
Akbar, Mohammed G K; Tamura, Yutaka; Ding, Min et al. (2006) Inhibition of hemoglobin S polymerization in vitro by a novel 15-mer EF-helix beta73 histidine-containing peptide. Biochemistry 45:8358-67
Adachi, Kazuhiko; Ding, Min; Surrey, Saul et al. (2006) The Hb A variant (beta73 Asp-->Leu) disrupts Hb S polymerization by a novel mechanism. J Mol Biol 362:528-38
Asakura, Toshio; Asakura, Kenji; Obata, Kazuo et al. (2005) Blood samples collected under venous oxygen pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: constancy of the percentage of sickled cells in individual patients during steady state. Am J Hematol 80:249-56

Showing the most recent 10 out of 140 publications